{"id":"almagate","rwe":[],"tags":[{"label":"almagate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A02AD03","category":"atc"},{"label":"Active","category":"status"},{"label":"Antacids","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["almagate"],"offLabel":[],"synonyms":["almagate"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"almagate","explanation":"Think of it like a sponge that soaks up extra phosphate in the body, helping to balance levels and prevent problems. This can be especially important for people with conditions that cause phosphate buildup, like kidney disease. By removing excess phosphate, almagate can help reduce symptoms and improve quality of life.","oneSentence":"Almagate works by binding to and removing excess phosphate ions from the body.","technicalDetail":"Almagate is a phosphate-binding agent that chelates phosphate ions, forming an insoluble complex that is excreted in the feces, thereby reducing phosphate absorption and promoting phosphate homeostasis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4435","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALMAGATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:37:43.831572","biosimilars":[],"competitors":[{"drugName":"almasilate","drugSlug":"almasilate","fdaApproval":"","relationship":"same-class"}],"genericName":"almagate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"almasilate","brandName":"almasilate","genericName":"almasilate","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000021334","MMSL":"d07853","NDDF":"010871","UNII":"568Z59H7ZJ","VUID":"4023329","VANDF":"4023329","INN_ID":"4586","RXNORM":"1029441","UMLSCUI":"C2936735","ChEMBL_ID":"CHEMBL3833390","KEGG_DRUG":"D02821","SNOMEDCT_US":"412560007","MESH_SUPPLEMENTAL_RECORD_UI":"C043698"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Nephrology"],"atcClassification":{"source":"DrugCentral","atcCode":"A02AD03","allCodes":["A02AD03"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"ALMAGATE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Almagate is a small molecule drug in the almagate class, originally developed by an unknown entity and currently owned by an unknown entity. Its target and exact mechanism of action are not specified. Almagate is used to treat unknown indications, and its commercial status, including patent status and generic availability, is unclear. The safety profile of almagate is also unknown. Further research is needed to fully understand this medication.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}